Boide Pharmaceuticals (688073.SH) disclosed the third quarter report of 2024, during the reporting period, the company achieved revenue of 8.1...
Zhītōng Finance APP News, Boide Pharmaceuticals (688073.SH) disclosed the third quarter report of 2024, during the reporting period, the company achieved revenue of 0.811 billion yuan, a year-on-year increase of 0.79%; net profit attributable to the parent company was 83.85 million yuan, a year-on-year decrease of 26.05%; non-recurring net income was 72.39 million yuan, a year-on-year decrease of 40.18%; basic earnings per share was 0.94 yuan.
